-transparent.png){kind=logo}
The synthesis and anti-RSV (Rouse Sarcoma Virus) activity of HMCA, (+/-)-9-(2-hydroxymethyl-cyclopenthyl)-adenine, and its derivatives are described. It has been demonstrated that trans-HMCA has greater anti-RSV activity in tissue culture than cis-HMCA.
Related Publications
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
February 2012,
Bioorganic & medicinal chemistry letters,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
November 2010,
Chemical & pharmaceutical bulletin,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
January 2023,
Frontiers in pharmacology,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
March 2010,
Journal of agricultural and food chemistry,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
January 2022,
Journal of natural products,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
March 2023,
Pharmaceuticals (Basel, Switzerland),
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
May 2006,
Journal of medicinal chemistry,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
July 2003,
Antiviral chemistry & chemotherapy,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
January 2020,
Journal of agricultural and food chemistry,
E Kojima, and
K Ohta, and
S Miyawaki, and
T Date, and
M Machida, and
K Murakami
November 2008,
Journal of agricultural and food chemistry,
